EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules

Grégoire D'Andréa iD, Jocelyn Gal, Loïc Mandine, Olivier Dassonville, Clair Vandersteen, Nicolas Guevara, Laurent Castillo, Gilles Poissonnet, Dorian Culié, Roxane Elaldi, Jérôme Sarini, Anne Decotte und 6 weitere

European Journal of Endocrinology · 2023

DOI: 10.1093/ejendo/lvad017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2023. Verfasst von Grégoire D'Andréa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology and Head and Neck Surgery Department, Institut Universitaire de la Face et du Cou, GHS Nice University Hospital-Antoine Lacassagn…. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Indeterminate thyroid nodules (ITN) are common and often lead to (sometimes unnecessary) diagnostic surgery. We aimed to evaluate the performance of two machine learning methods (ML), based on routinely available features to predict the risk of malignancy (RM) of ITN.

Design

Multi-centric diagnostic retrospective cohort study conducted between 2010 and 2020.

Methods

Adult patients who underwent surgery for at least one Bethesda III-V thyroid nodule (TN) with fully available medical records were included. Of the 7917 records reviewed, eligibility criteria were met in 1288 patients with 1335 TN. Patients were divided into training (940 TN) and validation cohort (395 TN). The diagnostic performance of a multivariate logistic regression model (LR) and its nomogram, and a random forest model (RF) in predicting the nature and RM of a TN were evaluated. All available clinical, biological, ultrasound, and cytological data of the patients were collected and used to construct the two algorithms.

Results

There were 253 (19%), 693 (52%), and 389 (29%) TN classified as Bethesda III, IV, and V, respectively, with an overall RM of 35%. Both cohorts were well-balanced for baseline characteristics. Both models were validated on the validation cohort, with performances in terms of specificity, sensitivity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve of 90%, 57.3%, 73.4%, 81.4%, 84% (CI95%: 78.5%-89.5%) for the LR model, and 87.6%, 54.7%, 68.1%, 80%, 82.6% (CI95%: 77.4%-87.9%) for the RF model, respectively.

Conclusions

Our ML models performed well in predicting the nature of Bethesda III-V TN. In addition, our freely available online nomogram helped to refine the RM, identifying low-risk TN that may benefit from surveillance in up to a third of ITN, and thus may reduce the number of unnecessary surgeries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NoduleThyroid NeoplasmsAdultHumansRetrospective StudiesBiopsy, Fine-NeedleRisk Factors

Stichwörter der Autor:innen

cytopathological featuresmachine learningpredictive modelrisk of malignancythyroid cancerthyroid nodulesultrasonographic features

Autor:innen und Institutionen

  • Otorhinolaryngology and Head and Neck Surgery Department, Institut Universitaire de la Face et du Cou, GHS Nice University Hospital-Antoine Lacassagne Centre, Côte d'Azur University, Nice 06103, France.
  • Department of Statistics, Centre Antoine Lacassagne, Nice 06103, France.
  • Otorhinolaryngology and Head and Neck Surgery Department, University Cancer Institute of Toulouse-Oncopole, Toulouse 31400, France.
  • Otorhinolaryngology and Head and Neck Surgery Department, Toulouse University Hospital, Hôpital Larrey, Toulouse 31400, France.
  • Thoracic Surgery Department, Toulouse University Hospital, Hôpital Larrey, Toulouse 31400, France.

ORCID-Profile: Grégoire D'Andréa

Zitieren

APA

D'Andréa, G., Gal, J., Mandine, L., Dassonville, O., Vandersteen, C., Guevara, N., Castillo, L., Poissonnet, G., Culié, D., Elaldi, R., Sarini, J., Decotte, A., Renaud, C., Vergez, S., Schiappa, R., Chamorey, E., Château, Y., & Bozec, A. (2023). Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad017

Vancouver

D'Andréa G, Gal J, Mandine L, Dassonville O, Vandersteen C, Guevara N, et al. Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules. European Journal of Endocrinology. 2023. doi:10.1093/ejendo/lvad017

BibTeX
@article{DAndra2023,
  author = {D'Andréa, Grégoire and Gal, Jocelyn and Mandine, Loïc and Dassonville, Olivier and Vandersteen, Clair and Guevara, Nicolas and Castillo, Laurent and Poissonnet, Gilles and Culié, Dorian and Elaldi, Roxane and Sarini, Jérôme and Decotte, Anne and Renaud, Claire and Vergez, Sébastien and Schiappa, Renaud and Chamorey, Emmanuel and Château, Yann and Bozec, Alexandre},
  title = {Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules},
  journal = {European Journal of Endocrinology},
  year = {2023},
  doi = {10.1093/ejendo/lvad017}
}
Kostenlos starten →